PulseAugur
EN
LIVE 19:40:01

Perceptic raises $12M to automate drug discovery with AI

By PulseAugur Editorial · [1 sources] ·

Perceptic, a startup founded by former Palantir executives, has emerged from stealth with $12 million in seed funding to automate the entire drug discovery process. The company's AI platform aims to integrate disparate AI tools and data for pharmaceutical companies, covering areas from asset scouting to clinical trial design. Perceptic's software is already in use by major pharmaceutical clients, including CSL, and is designed to be model-agnostic, allowing integration with existing customer infrastructure. AI

IMPACT Accelerates AI adoption in pharmaceutical R&D, potentially speeding up drug development timelines.

RANK_REASON Startup emerges from stealth with significant seed funding and notable backers. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on Fortune →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Perceptic raises $12M to automate drug discovery with AI

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Startup emerges from stealth with significant seed funding and notable backers. [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
123 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Fortune TIER_1 English(EN) · Jeremy Kahn ·

    Exclusive: Perceptic, a startup automating drug discovery end-to-end for Big Pharma, emerges from stealth with $12 million in seed funding

    Three former Palantir AI execs founded Perceptic, which is getting funding from Accel, Air Street Capital, and Elder Gull.

RELATED ENTITIES

RELATED TOPICS